Latest news
Gilead raises full-year guidance on 8% Q2 sales growth, eyes three near-term regulatory approvals - AllSciAllSci · Wed, 05 Aug 2026 14:17:35 GMTFDA weighs a new kind of flu shot based on technology RFK Jr. has questioned - NPRNPR · Sat, 01 Aug 2026 07:00:00 GMTOncoSil Medical (ASX: OSL): FDA Decision Nears - KalkineKalkine · Wed, 29 Jul 2026 12:44:00 GMT